Kura Oncology, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Kura Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Kura Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$54.4M, a 40.9% decline year-over-year.
  • Kura Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$198M, a 38.2% decline year-over-year.
  • Kura Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$153M, a 12.4% decline from 2022.
  • Kura Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$136M, a 4.12% decline from 2021.
  • Kura Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$130M, a 45.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$198M -$54.4M -$15.8M -40.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$182M -$50.8M -$13.7M -36.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$168M -$49.5M -$15.5M -45.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$153M -$42.8M -$9.67M -29.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$143M -$38.6M -$3.1M -8.73% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$140M -$37.2M -$2.41M -6.92% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$137M -$34.1M -$1.62M -4.98% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$136M -$33.1M -$371K -1.13% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$135M -$35.5M -$2.14M -6.41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$133M -$34.8M -$1.11M -3.29% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$132M -$32.5M -$1.76M -5.73% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$130M -$32.7M -$6.58M -25.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$124M -$33.4M -$9.6M -40.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$114M -$33.7M -$13.2M -64.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$101M -$30.7M -$11.5M -59.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$89.6M -$26.2M -$8.29M -46.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$81.3M -$23.8M -$7.38M -45% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$74M -$20.5M -$5.54M -37.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$68.4M -$19.2M -$5.27M -37.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$63.1M -$17.9M -$1.77M -11% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-25
Q3 2019 -$61.4M -$16.4M -$1.39M -9.23% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$60M -$14.9M -$204K -1.38% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$59.8M -$13.9M +$664K +4.55% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 -$60.4M -$16.1M -$5.35M -49.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-25
Q3 2018 -$55.1M -$15M -$5.67M -60.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-25
Q2 2018 -$49.4M -$14.7M -$6.92M -88.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-25
Q1 2018 -$42.5M -$14.6M -$7.07M -93.9% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-25
Q4 2017 -$35.4M -$10.7M -$3.4M -46.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 -$32M -$9.33M -$2.41M -34.8% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$29.6M -$7.82M -$1.16M -17.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 -$28.5M -$7.53M -$907K -13.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$27.6M -$7.35M -$873K -13.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$26.7M -$6.93M -$836K -13.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$25.9M -$6.66M -$1.08M -19.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$24.8M -$6.63M -$2.15M -48% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$22.6M -$6.47M -$2.8M -76.4% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$19.8M -$6.09M -$6.08M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$13.7M -$5.59M -$5.58M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 -$8.16M -$4.48M -$4.47M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$3.69M -$3.67M -$3.66M -37551% Aug 22, 2014 Dec 31, 2014 10-K 2016-03-17
Q3 2014 -$28.8K -$6.43K* -$289 Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-14
Q2 2014 -$28.5K -$6.89K* -$138 Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-14
Q1 2014 -$28.4K -$5.77K* +$207 Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-15
Q4 2013 -$28.6K -$9.75K -$88 -0.91% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 -$28.5K -$6.14K* -$126 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$28.4K -$6.75K* -$481 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$27.9K -$5.97K* -$601 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$27.3K -$9.66K -$778 -8.76% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 -$26.5K -$6.01K* +$254 Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$26.8K -$6.27K* +$467 Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$27.3K -$5.37K* -$218 Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$27K -$8.88K Oct 1, 2011 Dec 31, 2011 10-K 2015-02-27
Q3 2011 -$6.27K* -$1.5K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$6.74K* -$1.16K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$5.15K* Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$4.77K* Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$5.58K* Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.